By Michele Maatouk
Date: Tuesday 21 Oct 2025
(Sharecast News) - RBC Capital Markets lifted its price target on CVS Group on Tuesday after the Competition and Markets Authority announced the findings of its two-year investigation into the vet market last week and suggested remedies.
Posting of Annual Report & Notice of AGM | 17-Oct-2025 | 07:00 | RNS |
Response to CMA provisional decision announcement | 15-Oct-2025 | 07:35 | RNS |
Final results for the year ended 30 June 2025 | 07-Oct-2025 | 07:00 | RNS |
Total Voting Rights | 30-Sep-2025 | 07:00 | RNS |
PDMR Shareholding Correction | 15-Sep-2025 | 16:50 | RNS |
Vet chain’s £40m for acquisitions | 22-Dec-2011 | The Scotsman |
Questor : CVS Group | 21-Oct-2010 | Telegraph |
Questor:CVS Group | 06-Oct-2009 | Telegraph |
Tempus:CVS Group | 23-Sep-2009 | Times |
Oil sector begins recovery | 11-Oct-2007 | Guardian |
Tempus: CVS Group | 11-Oct-2007 | Times |
No recent information was found.
Currency | UK Pounds |
Share Price | 1,420.00p |
Change Today | 24.00p |
% Change | 1.72 % |
52 Week High | 1,448.00p |
52 Week Low | 798.00p |
Volume | 311,515 |
Shares Issued | 71.74m |
Market Cap | £1,018.71m |
RiskGrade | 136 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 5 |
Buy | 2 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 06-Nov-25 | 31-Oct-24 |
Paid | 05-Dec-25 | 29-Nov-24 |
Amount | 8.50p | 8.00p |
Time | Volume / Share Price |
16:37 | 5,000 @ 1,420.00p |
16:35 | 288 @ 1,420.00p |
16:35 | 31 @ 1,420.00p |
16:35 | 112 @ 1,420.00p |
16:35 | 28,784 @ 1,420.00p |
CEO | Richard Fairman |
Finance Director | Robin Alfonso |
You are here: research